Cargando…

GBA1 Variants and Parkinson’s Disease: Paving the Way for Targeted Therapy

Glucosylceramidase beta 1 (GBA1) variants have attracted enormous attention as the most promising and important genetic candidates for precision medicine in Parkinson’s disease (PD). A substantial correlation between GBA1 genotypes and PD phenotypes could inform the prediction of disease progression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huh, Young Eun, Usnich, Tatiana, Scherzer, Clemens R., Klein, Christine, Chung, Sun Ju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Movement Disorder Society 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548077/ https://www.ncbi.nlm.nih.gov/pubmed/37302978 http://dx.doi.org/10.14802/jmd.23023

Ejemplares similares

Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI
por: Huh, Young Eun, et al.
Publicado: (2021)

GBA1 in Parkinson’s disease: variant detection and pathogenicity scoring matters
por: Gabbert, Carolin, et al.
Publicado: (2023)

Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson’s disease
por: Stoker, Thomas B, et al.
Publicado: (2020)

GBA Variants and Parkinson Disease: Mechanisms and Treatments
por: Smith, Laura, et al.
Publicado: (2022)

A common polymorphism in SNCA is associated with accelerated motor decline in GBA-Parkinson’s disease
por: Stoker, Thomas B, et al.
Publicado: (2020)

Experience in Genetic Counseling for GBA1 Variants in Parkinson's Disease
por: den Heijer, Jonas M., et al.
Publicado: (2020)

Paving the way to metastasis
por: Van Epps, Heather L.
Publicado: (2005)

Role of Lysosomal Gene Variants in Modulating GBA ‐Associated Parkinson's Disease Risk
por: Straniero, Letizia, et al.
Publicado: (2022)

Paving the way to improve therapy for Myeloproliferative Neoplasms
por: Bywater, Megan, et al.
Publicado: (2022)

The Consequences of GBA Deficiency in the Autophagy–Lysosome System in Parkinson’s Disease Associated with GBA
por: Pradas, Eddie, et al.
Publicado: (2023)

GBA Variants Influence Motor and Non-Motor Features of Parkinson’s Disease
por: Jesús, Silvia, et al.
Publicado: (2016)

Paving the Way for Apollo 11
por: Harland, David M
Publicado: (2009)

Metabolomics paves the way for improved drug target identification
por: Garana, Belinda B, et al.
Publicado: (2022)

Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression
por: Ortega, Roberto A., et al.
Publicado: (2021)

Gene Therapy for Parkinson’s Disease Associated with GBA1 Mutations
por: Abeliovich, Asa, et al.
Publicado: (2021)

Comparative Transcriptome Analysis in Monocyte-Derived Macrophages of Asymptomatic GBA Mutation Carriers and Patients with GBA-Associated Parkinson’s Disease
por: Usenko, Tatiana, et al.
Publicado: (2021)

Dual-Task Performance in GBA Parkinson's Disease
por: Srulijes, Karin, et al.
Publicado: (2017)

Nuclear spindles pave the way to metastasis
por: Hensley, Patrick J., et al.
Publicado: (2017)

Understanding cell signalling systems: paving the way for new therapies
por: Jones, E. Yvonne
Publicado: (2015)

Characterization of a pathogenic variant in GBA for Parkinson’s disease with mild cognitive impairment patients
por: Jiang, Zhiqiang, et al.
Publicado: (2020)

Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease Onset
por: Schierding, William, et al.
Publicado: (2020)

Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review
por: Behl, Tapan, et al.
Publicado: (2021)

No evidence for substrate accumulation in Parkinson brains with GBA mutations
por: Gegg, Matthew E., et al.
Publicado: (2015)

Unraveling Autonomic Dysfunction in GBA‐Related Parkinson's Disease
por: Devigili, Grazia, et al.
Publicado: (2023)

Putative second hit rare genetic variants in families with seemingly GBA-associated Parkinson’s disease
por: Aslam, Muhammad, et al.
Publicado: (2021)

Mutational spectrum and clinical features of GBA1 variants in a Chinese cohort with Parkinson’s disease
por: Zhou, Yangjie, et al.
Publicado: (2023)

Is Gauchian genotyping of GBA1 variants reliable?
por: Tayebi, Nahid, et al.
Publicado: (2023)

Proteomics paves the way for Q fever diagnostics
por: Kowalczewska, Malgorzata, et al.
Publicado: (2011)

Cern paves the way for lightning-speed networks
Publicado: (2008)

Cytokines in Bipolar Disorder: Paving the Way for Neuroprogression
por: Barbosa, Izabela Guimarães, et al.
Publicado: (2014)

BioMiner: Paving the Way for Personalized Medicine
por: Bauer, Chris, et al.
Publicado: (2015)

Paving the way toward better peer review
Publicado: (2016)

Paving the Way to Precision Nutrition Through Metabolomics
por: Tebani, Abdellah, et al.
Publicado: (2019)

Optical Imaging Paves the Way for Autophagy Research
por: Wang, Yimin, et al.
Publicado: (2017)

SARS sequencing paves the way for better diagnostics
por: Ahmad, Khabir
Publicado: (2003)

Paving the Way for Fertilization: The Role of the Transmitting Tract
por: Pereira, Ana Marta, et al.
Publicado: (2021)

Excellence paves the way with Current Research in Toxicology
por: Knudsen, Thomas B., et al.
Publicado: (2020)

Commentary: Paving the way with visualization of the invisible craftsmanship
por: Nakamura, Shota, et al.
Publicado: (2021)

Clearing the radiotherapy backlog: innovation to pave the way
por: The Lancet Oncology
Publicado: (2022)

Paving the way for the oncological process in patients with schizophrenia
por: Casanovas, F., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nd4tn4k6borhl40tdv0dthnk36